LiveOpenAI Raises $11 Billion So Far at a $1.25 Trillion Valuation, Short of Its $30 Billion Goal
    WYDE
    Sign inSubscribe
    WYDE Newsroom Submit
    company

    Moderna

    Moderna is a company that develops medicines and vaccines based on mRNA science. It was known as ModeRNA Therapeutics from 2010 to 2018. Its mission is to create a new generation of transformative medicines for patients.

    modernatx.com
    Chief Executive Officer
    Stéphane Bancel

    Key facts

    Founded
    September 2010source
    Nasdaq IPO, December 7, 2018
    raising $621 million by selling 27 million shares at $23 per sharesource
    CEPI funding for Bundibugyo ebolavirus vaccine candidate (mRNA-1469)
    up to US$50 millionsource
    First dose in Phase 1 trial of mRNA-1469
    August 3, 2026, in Truro, Nova Scotiasource
    Mission
    deliver on the promise of mRNA science to create a new generation of transformative medicines for patientssource

    WYDE coverage of Moderna

    WYDE Newsroom has published 2 articles about Moderna, from Aug 6, 2026 to Aug 8, 2026. Moderna is the subject of 2 stories. The most recent is A Judge Ordered Meta to Pay $567 Million, Another Gave HHS Until Noon, and the Farm Bill Died by One Vote. Over 63,000 Meals..

    Reported alongside Moderna

    Sources

    Track the institutions that move money.

    Data-driven coverage, every week.